Lithium shield: could a mood drug guard the brain during neck surgery?
NCT ID NCT05126238
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested whether giving lithium carbonate before carotid artery surgery could reduce brain damage and confusion after the operation. The trial planned to include 107 adults undergoing elective carotid surgery, but it was terminated early. The goal was to see if lithium could prevent problems like delirium and memory issues that sometimes occur when blood flow to the brain is temporarily stopped during surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
107 people
The number who actually took part.
- Started
-
Nov 2021
- Finished
-
May 2025
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * age \> 18 years * elective carotid artery surgery * general anesthesia * written informed consent Exclusion Criteria: * urgent surgery * recent ( \< 1 month) overt stroke * Mini-mental State Examination \< 20 points * The presence of any mental disorder according to the International Classification of Diseases 11th Revision which is confirmed by a psychiatrist. * The presence of any neuromuscular disease according to the International Classification of Diseases 11th Revision * Hypersensitivity or known allergy to lithium carbonate * History of seizure disorder * History of leukemia * Estimated glomerular filtration rate \< 30 ml/min/1.73 m2 * Left ventricular ejection fraction \< 30% * Heart failure equal 3 or 4 class according to the New York Heart Association Functional Classification * Pregnant or breast-feeding women * Inability to undergo a preoperative assessment for any reason * Previously enrolled in this trial
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Carotid artery diseases are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Demikhov Municipal Clinical Hospital 68
Moscow, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which patch keeps the carotid artery open longer?
- Could a stent double the chance of a good recovery after severe stroke?
- Can a new CT scanner see carotid plaques better?
- New PET tracer could spot dangerous plaques before they cause strokes
- Could an arthritis drug shield heart and kidneys in metabolic syndrome?
- Could a double-barrel cholesterol drug shrink artery plaque better than statins alone?